Follow
Olivier Reynard
Olivier Reynard
CIRI
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti–interleukin 10 receptor antibody
AP Vicari, C Chiodoni, C Vaure, S Aït-Yahia, C Dercamp, F Matsos, ...
The Journal of experimental medicine 196 (4), 541-549, 2002
4602002
Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs
KC Prins, S Delpeut, DW Leung, O Reynard, VA Volchkova, SP Reid, ...
Journal of virology 84 (6), 3004-3015, 2010
1792010
VP40 octamers are essential for Ebola virus replication
T Hoenen, V Volchkov, L Kolesnikova, E Mittler, J Timmins, M Ottmann, ...
Journal of virology 79 (3), 1898-1905, 2005
1422005
Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs
VA Volchkova, O Dolnik, MJ Martinez, O Reynard, VE Volchkov
The Journal of infectious diseases 204 (suppl_3), S941-S946, 2011
1182011
Role of Ebola virus VP30 in transcription reinitiation
MJ Martinez, N Biedenkopf, V Volchkova, B Hartlieb, N Alazard-Dany, ...
Journal of virology 82 (24), 12569-12573, 2008
1132008
Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins
O Reynard, M Borowiak, VA Volchkova, S Delpeut, M Mateo, VE Volchkov
Journal of virology 83 (18), 9596-9601, 2009
1072009
Identification of a new ribonucleoside inhibitor of Ebola virus replication
O Reynard, XN Nguyen, N Alazard-Dany, V Barateau, A Cimarelli, ...
Viruses 7 (12), 6233-6240, 2015
1002015
Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level
N Alazard-Dany, V Volchkova, O Reynard, C Carbonnelle, O Dolnik, ...
Journal of general virology 87 (5), 1247-1257, 2006
962006
VP24 is a molecular determinant of Ebola virus virulence in guinea pigs
M Mateo, C Carbonnelle, O Reynard, L Kolesnikova, K Nemirov, A Page, ...
The Journal of Infectious Diseases 204 (suppl_3), S1011-S1020, 2011
922011
Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1
A Page, VA Volchkova, SP Reid, M Mateo, A Bagnaud-Baule, K Nemirov, ...
Cell reports 6 (6), 1026-1036, 2014
902014
Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication
M Mateo, C Carbonnelle, MJ Martinez, O Reynard, A Page, VA Volchkova, ...
The Journal of infectious diseases 204 (suppl_3), S892-S896, 2011
822011
Role of VP30 phosphorylation in the Ebola virus replication cycle
MJ Martinez, VA Volchkova, H Raoul, N Alazard-Dany, O Reynard, ...
The Journal of infectious diseases 204 (suppl_3), S934-S940, 2011
712011
Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs
K Tartour, XN Nguyen, R Appourchaux, S Assil, V Barateau, LM Bloyet, ...
PLoS pathogens 13 (9), e1006610, 2017
682017
In vivo Manipulation of Dendritic Cell Migration and Activation to Elicit Antitumour Immunity
AP Vicari, B Vanbervliet, C Massacrier, C Chiodoni, C Vaure, S Aït‐Yahia, ...
Cancer and Inflammation: Novartis Foundation Symposium 256 256, 241-258, 2004
532004
Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection
O Reynard, V Mokhonov, E Mokhonova, J Leung, A Page, M Mateo, ...
The Journal of infectious diseases 204 (suppl_3), S1060-S1065, 2011
492011
Human transmission of Ebola virus
P Lawrence, N Danet, O Reynard, V Volchkova, V Volchkov
Current opinion in virology 22, 51-58, 2017
422017
RNA editing of the GP gene of Ebola virus is an important pathogenicity factor
VA Volchkova, O Dolnik, MJ Martinez, O Reynard, VE Volchkov
The Journal of infectious diseases 212 (suppl_2), S226-S233, 2015
372015
Characterization of a novel neutralizing monoclonal antibody against Ebola virus GP
O Reynard, VE Volchkov
The Journal of infectious diseases 212 (suppl_2), S372-S378, 2015
332015
Conserved proline-rich region of Ebola virus matrix protein VP40 is essential for plasma membrane targeting and virus-like particle release
O Reynard, K Nemirov, A Page, M Mateo, H Raoul, W Weissenhorn, ...
The Journal of infectious diseases 204 (suppl_3), S884-S891, 2011
322011
Enhancement of Ebola virus infection via ficolin-1 interaction with the mucin domain of GP glycoprotein
AL Favier, E Gout, O Reynard, O Ferraris, JP Kleman, V Volchkov, ...
Journal of Virology 90 (11), 5256-5269, 2016
292016
The system can't perform the operation now. Try again later.
Articles 1–20